Is USVM or ABBV a better dividend investment in 2026?

USVM currently yields 1.96% with a 5% 5-year dividend growth rate. ABBV yields 3.67% with 8.9% growth. The better choice depends on your goal: ABBV offers higher current income.

What is the dividend yield difference between USVM and ABBV?

USVM has a forward dividend yield of 1.96% ($1.81/share annually). ABBV yields 3.67% ($6.20/share annually). The yield gap is 1.71 percentage points.

Home › Compare › USVM vs ABBV

USVM vs ABBV: Dividend Comparison 2026

USVM yields 1.96% · ABBV yields 3.67%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ABBV wins by $17.4K in total portfolio value

INVESTMENT

TIME HORIZON10 years

USVM

● Live price

1.96%

Share price

$92.49

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.5K

Annual income

$222.14

Full USVM calculator →

ABBV

AbbVie Inc.

● Live price

3.67%

Share price

$168.90

Annual div

$6.20

5Y div CAGR

8.9%

Payout ratio

58%

After 10 yrs · $10,000 · DRIP

Portfolio value

$39.9K

Annual income

$1,154.43

Full ABBV calculator →

Portfolio growth — USVM vs ABBV

📍 ABBV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	USVM	ABBV
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, USVM + ABBV cover 4 of 12 months — good coverage

Jan

ABBV

Feb

—

Mar

—

Apr

ABBV

May

—

Jun

—

Jul

ABBV

Aug

—

Sep

—

Oct

ABBV

Nov

—

Dec

—

USVM pays

ABBV pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

USVM

Annual income on $10K today (after 15% tax)

$166.37/yr

After 10yr DRIP, annual income (after tax)

$188.82/yr

ABBV

Annual income on $10K today (after 15% tax)

$312.02/yr

After 10yr DRIP, annual income (after tax)

$981.27/yr

At 15% tax rate, ABBV beats the other by $792.45/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of USVM + ABBV for your $10,000?

USVM: 50%ABBV: 50%

100% ABBV50/50100% USVM

Portfolio after 10yr

$31.2K

Annual income

$688.29/yr

Blended yield

2.20%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

USVM

No analyst data

ABBV

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$256.15

+51.7% upside vs current

Range: $223.00 — $299.00

Altman Z

2.0

Piotroski

8/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

USVM buys

ABBV buys

No recent congressional trades found for USVM or ABBV in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricUSVMABBV

Forward yield	1.96%	3.67% ✓
Annual dividend / share	$1.81	$6.20 ✓
Payout ratio	50% ✓	58%
1-year div growth	0%	4.7% ✓
5-year div CAGR	0%	8.9% ✓
Portfolio after 10y	$22.5K	$39.9K ✓
Annual income after 10y	$222.14	$1,154.43 ✓
Total dividends collected	$2.1K	$7.2K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: USVM vs ABBV ($10,000, DRIP)

Year	USVM Portfolio	USVM Income/yr	ABBV Portfolio	ABBV Income/yr	Gap
1← crossover	$10,896	$195.73	$11,520	$399.75	$624.00 → ABBV
2	$11,858	$199.31	$13,261	$450.98	$1.4K → ABBV
3	$12,890	$202.72	$15,255	$508.41	$2.4K → ABBV
4	$13,999	$205.95	$17,536	$572.74	$3.5K → ABBV
5	$15,188	$209.03	$20,145	$644.78	$5.0K → ABBV
6	$16,463	$211.95	$23,126	$725.38	$6.7K → ABBV
7	$17,830	$214.71	$26,532	$815.52	$8.7K → ABBV
8	$19,295	$217.33	$30,420	$916.26	$11.1K → ABBV
9	$20,866	$219.80	$34,855	$1,028.80	$14.0K → ABBV
10	$22,549	$222.14	$39,914	$1,154.43	$17.4K → ABBV

USVM vs ABBV: Complete Analysis 2026

USVM — Stock

Seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the Nasdaq Victory US Small Mid Cap Value Momentum Index. The Index is designed to deliver exposure to equity securities of small and mid capitalization issuers that have higher exposure to value and momentum factors while also maintaining moderate turnover and lower realized volatility than traditional capitalization weighted indexes.

Full USVM Calculator →

ABBV — Healthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →

📬

Get this USVM vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

USVM vs SCHD USVM vs JEPI USVM vs O USVM vs KO USVM vs MAIN USVM vs JNJ USVM vs MRK USVM vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.